Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fletcher

Showing results (751-760 of 805) with videos related to

Pageof 81
Sort By:
JAMA|February 12, 1997
Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study GroupA M Fein, G R Bernard, G J Criner, et al.
Cancer Cell|July 22, 2014
Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agentJacqueline M Mason, Dan Chi-Chia Lin, Xin Wei, et al.
Psychopharmacology|June 29, 2005
Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval taskGarry D Honey, Rebekah A E Honey, Sam R Sharar, et al.
Nature Communications|September 18, 2013
Master regulators of FGFR2 signalling and breast cancer riskMichael N C Fletcher, Mauro A A Castro, Xin Wang, et al.
Biological Psychiatry|December 19, 2012
Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese peopleVictoria C Cambridge, Hisham Ziauddeen, Pradeep J Nathan, et al.
Archives of General Psychiatry|April 8, 2009
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosisSagnik Bhattacharyya, Paolo Fusar-Poli, Stefan Borgwardt, et al.
Neuropsychologia|April 12, 2011
Hippocampal dysfunction in patients with mild cognitive impairment: a functional neuroimaging study of a visuospatial paired associates learning taskMischa de Rover, Valentino A Pironti, Jonathan A McCabe, et al.
Journal of Intellectual Disability Research : JIDR|May 29, 2015
Novel insights into maladaptive behaviours in Prader-Willi syndrome: serendipitous findings from an open trial of vagus nerve stimulationK E Manning, C J McAllister, H A Ring, et al.
Journal of Medicinal Chemistry|August 1, 2023
5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5Lennart Brewitz, Yu Nakashima, Sonia K Piasecka, et al.
Journal of Integrative Plant Biology|May 26, 2026
A CLE-RLK-LBD signaling module promotes de novo shoot regeneration in plantsZiyao Hu, Langrang Zhang, Siwei Bie, et al.
Pageof 81

Showing results (751-760 of 805) with videos related to

Sort By:
Pageof 81
JAMA|February 12, 1997
Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study GroupA M Fein, G R Bernard, G J Criner, et al.
Cancer Cell|July 22, 2014
Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agentJacqueline M Mason, Dan Chi-Chia Lin, Xin Wei, et al.
Psychopharmacology|June 29, 2005
Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval taskGarry D Honey, Rebekah A E Honey, Sam R Sharar, et al.
Nature Communications|September 18, 2013
Master regulators of FGFR2 signalling and breast cancer riskMichael N C Fletcher, Mauro A A Castro, Xin Wang, et al.
Biological Psychiatry|December 19, 2012
Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese peopleVictoria C Cambridge, Hisham Ziauddeen, Pradeep J Nathan, et al.
Archives of General Psychiatry|April 8, 2009
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosisSagnik Bhattacharyya, Paolo Fusar-Poli, Stefan Borgwardt, et al.
Neuropsychologia|April 12, 2011
Hippocampal dysfunction in patients with mild cognitive impairment: a functional neuroimaging study of a visuospatial paired associates learning taskMischa de Rover, Valentino A Pironti, Jonathan A McCabe, et al.
Journal of Intellectual Disability Research : JIDR|May 29, 2015
Novel insights into maladaptive behaviours in Prader-Willi syndrome: serendipitous findings from an open trial of vagus nerve stimulationK E Manning, C J McAllister, H A Ring, et al.
Journal of Medicinal Chemistry|August 1, 2023
5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5Lennart Brewitz, Yu Nakashima, Sonia K Piasecka, et al.
Journal of Integrative Plant Biology|May 26, 2026
A CLE-RLK-LBD signaling module promotes de novo shoot regeneration in plantsZiyao Hu, Langrang Zhang, Siwei Bie, et al.
Pageof 81